US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ensysce Biosciences Inc.

0.3733

-0.0045-1.19%

Post-market: 0.3636-0.0097-2.60%19:41 EDT

Volume:778.03K

Turnover:285.13K

Market Cap:7.26M

PE:-0.20

High:0.3745

Open:0.3705

Low:0.3624

Close:0.3778

52wk High:2.75

52wk Low:0.2300

Shares:19.46M

Float Shares:15.36M

Volume Ratio:0.15

T/O Rate:5.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9099

EPS(LYR):-3.9790

ROE:-1295.09%

ROA:-185.51%

PB:-9.29

PE(LYR):-0.09

Loading ...

Overview Company News Filings

BRIEF-Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing

Ensysce Biosciences Inc - Launches Formal Review of Strategic Alternatives - SEC Filing

THOMSON REUTERS

Ensysce Biosciences Q1 EPS $(0.52) Beats $(0.73) Estimate, Sales $960.999K Miss $1.900M Estimate

Benzinga Earnings

Ensysce Q1 FY26 net loss widens to $3.6 million

Ensysce announces expansion of patent protection for MPAR technology

Ensysce says Taiwan grants MPAR overdose-protection patent through 2042

Top Premarket Gainers

MT Newswires Live

Ensysce Biosciences Inc expected to post a loss of 73 cents a share - Earnings Preview

Ensysce CEO speaks at Pain Therapeutics Summit Europe in Amsterdam

Ensysce Biosciences posts investor presentation on TAAP, MPAR opioid pain programs

Ensysce secures IRB approval of final phase of PF614-MPAR-102 study

Ensysce gets IRB clearance to start final phase of PF614-MPAR-102 study

Ensysce Biosciences files to sell 20.34M shares of common stock for holders

Ensysce Biosciences secures second financing from 2025 agreement

Ensysce Biosciences closes USD 2 million convertible preferred stock private placement

Ensysce Biosciences director Curtis Rosebraugh resigns from board

Ensysce Biosciences Q4 EPS $(0.75) Misses $(0.70) Estimate, Sales $1.882M Beat $500.000K Estimate

Benzinga Earnings

Ensysce Biosciences Q4 net loss narrows to $2.8 mln

Ensysce FY25 net loss widens to $10 million; R&D expense climbs to $10 million

Ensysce Biosciences director Lee Rauch resigns from board amid retention package dispute

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ENSC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ENSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENSC\",,,,,undefined,":{"symbol":"ENSC","market":"US","secType":"STK","nameCN":"Ensysce Biosciences Inc.","latestPrice":0.3733,"timestamp":1787342400000,"preClose":0.3778,"halted":0,"volume":778034,"hourTrading":{"tag":"盘后","latestPrice":0.3636,"preClose":0.3733,"latestTime":"19:41 EDT","volume":38457,"amount":14177.54932,"timestamp":1787355698176,"change":-0.0097,"changeRate":-0.025984,"amplitude":0.028128},"delay":0,"changeRate":-0.011911064055055594,"floatShares":15355200,"shares":19456800,"eps":-1.909943,"marketStatus":"Not Yet Opened","change":-0.0045,"latestTime":"08-21 16:00:00 EDT","open":0.3705,"high":0.3745,"low":0.3624,"amount":285126.61014142004,"amplitude":0.032028,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.909943,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.3778,"preHourTrading":{"tag":"盘前","latestPrice":0.3706,"preClose":0.3778,"latestTime":"09:19 EDT","volume":41648,"amount":15606.021202240001,"timestamp":1787318387133,"change":-0.0072,"changeRate":-0.019058,"amplitude":0.056114},"postHourTrading":{"tag":"盘后","latestPrice":0.3636,"preClose":0.3733,"latestTime":"19:41 EDT","volume":38457,"amount":14177.54932,"timestamp":1787355698176,"change":-0.0097,"changeRate":-0.025984,"amplitude":0.028128},"volumeRatio":0.14571060737219965,"impliedVol":3.1521,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENSC\",,,,,undefined,":{"symbol":"ENSC","floatShares":15355200,"roa":"-185.51%","roe":"-1295.09%","lyrEps":-3.978959,"volumeRatio":0.14571060737219965,"shares":19456800,"dividePrice":0,"high":0.3745,"amplitude":0.032028,"preClose":0.3778,"low":0.3624,"week52Low":0.23,"pbRate":"-9.29","psRate":"1.61","week52High":2.75,"institutionHeld":0,"latestPrice":0.3733,"eps":-1.909943,"divideRate":0,"volume":778034,"delay":0,"ttmEps":-1.909943,"open":0.3705,"prevYearClose":0.92,"prevWeekClose":0.3999,"prevMonthClose":0.253,"prevQuarterClose":0.29,"fiveDayClose":0.3999,"twentyDayClose":0.2614,"sixtyDayClose":0.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENSC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ENSC","fiscalQuarterEnding":"2026/06","expectedEps":-0.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2026-05-15","symbol":"ENSC","fiscalQuarterEnding":"2026/03","expectedEps":-0.73,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2026-03-30","symbol":"ENSC","fiscalQuarterEnding":"2025/12","expectedEps":-1.26,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2025-11-14","symbol":"ENSC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-13","symbol":"ENSC","fiscalQuarterEnding":"2025/06","expectedEps":-1.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENSC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ENSC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ENSC","date":"2026-08-21","current":-0.195451,"percent":0.436631,"low":-1151.871294,"twenty":-0.985034,"median":-0.405593,"eighty":-0.228907,"high":-0.089484,"avg":-34.572735,"sd":154.76024,"marketCap":6130756},"quantilePoints":[{"date":"2021-08-27","current":-761.364824,"twenty":-747.61113,"median":789.758561,"eighty":1590.301804,"marketCap":75192390},{"date":"2021-09-03","current":-825.221223,"twenty":-767.750462,"median":676.332041,"eighty":1555.901866,"marketCap":81498848},{"date":"2021-09-10","current":-859.605437,"twenty":-780.52174,"median":598.835663,"eighty":1458.340968,"marketCap":84894633},{"date":"2021-09-17","current":-724.524585,"twenty":-780.52174,"median":555.860395,"eighty":1373.799461,"marketCap":71554048},{"date":"2021-09-24","current":-1102.750982,"twenty":-800.661067,"median":488.931707,"eighty":1361.174599,"marketCap":108907687},{"date":"2021-10-01","current":-704.876458,"twenty":-815.397165,"median":-708.560485,"eighty":1130.038123,"marketCap":69613599},{"date":"2021-10-08","current":-582.075678,"twenty":-800.661067,"median":-611.547874,"eighty":1000.40781,"marketCap":57485794},{"date":"2021-10-15","current":-582.075678,"twenty":-788.380994,"median":-604.17982,"eighty":986.317559,"marketCap":57485794},{"date":"2021-10-22","current":-547.691464,"twenty":-781.01294,"median":-601.723805,"eighty":986.303472,"marketCap":54090009},{"date":"2021-10-29","current":-540.32342,"twenty":-780.52174,"median":-596.811776,"eighty":885.234099,"marketCap":53362341},{"date":"2021-11-05","current":-552.603493,"twenty":-778.556926,"median":-582.075678,"eighty":880.640679,"marketCap":54575121},{"date":"2021-11-12","current":-542.779435,"twenty":-776.100911,"median":-575.935642,"eighty":879.231656,"marketCap":53604897},{"date":"2021-11-19","current":-2.041392,"twenty":-776.100911,"median":-559.971547,"eighty":796.099172,"marketCap":38445141},{"date":"2021-11-26","current":-2.034952,"twenty":-774.1361,"median":-555.059508,"eighty":785.954194,"marketCap":38323863},{"date":"2021-12-03","current":-1.609931,"twenty":-769.715274,"median":-550.147479,"eighty":769.891308,"marketCap":30319512},{"date":"2021-12-10","current":-5.705594,"twenty":-764.803244,"median":-542.779435,"eighty":694.367562,"marketCap":107452350},{"date":"2021-12-17","current":-3.812316,"twenty":-763.820838,"median":-539.095413,"eighty":648.151541,"marketCap":71796604},{"date":"2021-12-23","current":-6.594276,"twenty":-762.34723,"median":-537.867406,"eighty":615.743964,"marketCap":124188721},{"date":"2021-12-31","current":-6.053339,"twenty":-758.417601,"median":-6.594276,"eighty":588.690681,"marketCap":114001365},{"date":"2022-01-07","current":-5.138899,"twenty":-754.979176,"median":-6.175695,"eighty":578.5457,"marketCap":96779882},{"date":"2022-01-14","current":-4.224458,"twenty":-753.99677,"median":-5.705594,"eighty":551.774222,"marketCap":79558399},{"date":"2022-01-21","current":-3.078187,"twenty":-753.99677,"median":-5.692715,"eighty":524.720941,"marketCap":57970907},{"date":"2022-01-28","current":-2.150867,"twenty":-750.067147,"median":-5.409367,"eighty":500.767517,"marketCap":40506868},{"date":"2022-02-04","current":-2.073591,"twenty":-736.313461,"median":-5.254814,"eighty":478.223115,"marketCap":39051531},{"date":"2022-02-11","current":-2.073591,"twenty":-719.612556,"median":-4.939267,"eighty":276.652164,"marketCap":39051531},{"date":"2022-02-18","current":-1.39742,"twenty":-709.29729,"median":-4.623721,"eighty":-1.482424,"marketCap":26317336},{"date":"2022-02-25","current":-1.40386,"twenty":-687.68435,"median":-4.456288,"eighty":-1.367797,"marketCap":26438614},{"date":"2022-03-04","current":-1.378101,"twenty":-617.442308,"median":-4.218019,"eighty":-1.378101,"marketCap":25953502},{"date":"2022-03-11","current":-1.416739,"twenty":-611.056671,"median":-4.17294,"eighty":-1.367797,"marketCap":26681170},{"date":"2022-03-18","current":-1.584172,"twenty":-608.600654,"median":-3.915351,"eighty":-1.367797,"marketCap":29834399},{"date":"2022-03-25","current":-1.455377,"twenty":-606.635834,"median":-3.72216,"eighty":-1.378101,"marketCap":27408838},{"date":"2022-04-01","current":-0.909052,"twenty":-605.653428,"median":-3.026669,"eighty":-1.367797,"marketCap":26438614},{"date":"2022-04-08","current":-0.942412,"twenty":-601.723805,"median":-2.640286,"eighty":-1.243923,"marketCap":27408838},{"date":"2022-04-14","current":-0.892372,"twenty":-601.723805,"median":-2.31186,"eighty":-1.109211,"marketCap":25953502},{"date":"2022-04-22","current":-0.884033,"twenty":-599.267791,"median":-2.221704,"eighty":-0.942412,"marketCap":25710946},{"date":"2022-04-29","current":-0.917392,"twenty":-599.267791,"median":-2.189506,"eighty":-0.917392,"marketCap":26681170},{"date":"2022-05-06","current":-0.935552,"twenty":-594.355761,"median":-2.131548,"eighty":-0.917392,"marketCap":27209326},{"date":"2022-05-13","current":-0.797005,"twenty":-582.075678,"median":-2.08647,"eighty":-0.892372,"marketCap":23214444},{"date":"2022-05-20","current":-0.624837,"twenty":-582.075678,"median":-2.073591,"eighty":-0.867353,"marketCap":18199682},{"date":"2022-05-27","current":-0.62899,"twenty":-582.075678,"median":-2.041392,"eighty":-0.82967,"marketCap":18320644},{"date":"2022-06-03","current":-0.645958,"twenty":-578.146055,"median":-2.034952,"eighty":-0.778733,"marketCap":18814863},{"date":"2022-06-10","current":-0.587461,"twenty":-575.198838,"median":-1.960895,"eighty":-0.698325,"marketCap":17111019},{"date":"2022-06-17","current":-0.537744,"twenty":-566.848388,"median":-1.931917,"eighty":-0.663661,"marketCap":15662924},{"date":"2022-06-24","current":-0.547118,"twenty":-561.936359,"median":-1.803122,"eighty":-0.641971,"marketCap":15935954},{"date":"2022-07-01","current":-0.675147,"twenty":-559.971547,"median":-1.758044,"eighty":-0.628942,"marketCap":19665057},{"date":"2022-07-08","current":-0.740288,"twenty":-558.006731,"median":-1.63569,"eighty":-0.63179,"marketCap":21562441},{"date":"2022-07-15","current":-0.73318,"twenty":-554.077102,"median":-1.584172,"eighty":-0.639978,"marketCap":21355409},{"date":"2022-07-22","current":-0.750097,"twenty":-552.603493,"median":-1.526215,"eighty":-0.650372,"marketCap":21848142},{"date":"2022-07-29","current":-0.645214,"twenty":-550.638681,"median":-1.455377,"eighty":-0.648267,"marketCap":18793198},{"date":"2022-08-05","current":-0.542837,"twenty":-547.691464,"median":-1.436058,"eighty":-0.628919,"marketCap":15811251},{"date":"2022-08-12","current":-0.502219,"twenty":-545.726652,"median":-1.416739,"eighty":-0.623627,"marketCap":18104172},{"date":"2022-08-19","current":-0.4432,"twenty":-541.797029,"median":-1.400842,"eighty":-0.597747,"marketCap":15976634},{"date":"2022-08-26","current":-0.437558,"twenty":-540.32342,"median":-1.39098,"eighty":-0.585573,"marketCap":15773232},{"date":"2022-09-02","current":-0.436493,"twenty":-539.341014,"median":-1.39098,"eighty":-0.574176,"marketCap":15734855},{"date":"2022-09-09","current":-0.364844,"twenty":-537.867406,"median":-1.38776,"eighty":-0.560252,"marketCap":13152036},{"date":"2022-09-16","current":-0.333012,"twenty":-537.867406,"median":-1.378101,"eighty":-0.543432,"marketCap":12004543},{"date":"2022-09-23","current":-0.234109,"twenty":-537.376203,"median":-1.352342,"eighty":-0.508327,"marketCap":8439255},{"date":"2022-09-30","current":-0.228893,"twenty":-429.647968,"median":-1.243734,"eighty":-0.498322,"marketCap":8251204},{"date":"2022-10-07","current":-0.234216,"twenty":-6.555638,"median":-1.18844,"eighty":-0.457146,"marketCap":8443092},{"date":"2022-10-14","current":-0.220376,"twenty":-6.367598,"median":-1.109211,"eighty":-0.440474,"marketCap":7944182},{"date":"2022-10-21","current":-0.210262,"twenty":-6.210469,"median":-1.003086,"eighty":-0.435641,"marketCap":7579594},{"date":"2022-10-28","current":-0.250893,"twenty":-6.104857,"median":-0.950752,"eighty":-0.392333,"marketCap":9044283},{"date":"2022-11-04","current":-0.17653,"twenty":-5.98379,"median":-0.934812,"eighty":-0.354113,"marketCap":6363632},{"date":"2022-11-11","current":-0.1248,"twenty":-5.705594,"median":-0.917392,"eighty":-0.266963,"marketCap":4498831},{"date":"2022-11-18","current":-0.202801,"twenty":-5.703018,"median":-0.904882,"eighty":-0.252442,"marketCap":5824224},{"date":"2022-11-25","current":-0.338332,"twenty":-5.692715,"median":-0.892372,"eighty":-0.252314,"marketCap":9716511},{"date":"2022-12-02","current":-0.220875,"twenty":-5.666956,"median":-0.884033,"eighty":-0.252314,"marketCap":6343293},{"date":"2022-12-09","current":-0.218547,"twenty":-5.525282,"median":-0.867353,"eighty":-0.245714,"marketCap":6276429},{"date":"2022-12-16","current":-0.173271,"twenty":-5.293452,"median":-0.82967,"eighty":-0.238048,"marketCap":4976162},{"date":"2022-12-23","current":-0.160808,"twenty":-5.254814,"median":-0.801912,"eighty":-0.234216,"marketCap":4618230},{"date":"2022-12-30","current":-0.167485,"twenty":-5.254814,"median":-0.794791,"eighty":-0.233587,"marketCap":4809988},{"date":"2023-01-06","current":-0.162144,"twenty":-5.208448,"median":-0.777262,"eighty":-0.229014,"marketCap":4656609},{"date":"2023-01-13","current":-0.172083,"twenty":-5.154354,"median":-0.761172,"eighty":-0.22176,"marketCap":4942034},{"date":"2023-01-20","current":-0.151312,"twenty":-4.979194,"median":-0.754483,"eighty":-0.220248,"marketCap":4345527},{"date":"2023-01-27","current":-0.15636,"twenty":-4.713877,"median":-0.749721,"eighty":-0.212142,"marketCap":4490485},{"date":"2023-02-03","current":-0.285115,"twenty":-4.654632,"median":-0.740288,"eighty":-0.212142,"marketCap":8188175},{"date":"2023-02-10","current":-0.319777,"twenty":-4.577355,"median":-0.716973,"eighty":-0.2146,"marketCap":9183632},{"date":"2023-02-17","current":-0.306121,"twenty":-4.487199,"median":-0.704416,"eighty":-0.217004,"marketCap":8791464},{"date":"2023-02-24","current":-0.268404,"twenty":-4.453712,"median":-0.69164,"eighty":-0.21887,"marketCap":7708271},{"date":"2023-03-03","current":-0.278653,"twenty":-4.399619,"median":-0.674554,"eighty":-0.220206,"marketCap":8002622},{"date":"2023-03-10","current":-0.295605,"twenty":-4.221882,"median":-0.670756,"eighty":-0.220476,"marketCap":8489450},{"date":"2023-03-17","current":-0.319044,"twenty":-4.206427,"median":-0.666784,"eighty":-0.220988,"marketCap":9162596},{"date":"2023-03-24","current":-0.28195,"twenty":-4.183244,"median":-0.656993,"eighty":-0.221547,"marketCap":8097283},{"date":"2023-03-31","current":-0.251749,"twenty":-4.160061,"median":-0.645586,"eighty":-0.223101,"marketCap":6085356},{"date":"2023-04-06","current":-0.180809,"twenty":-4.108543,"median":-0.632491,"eighty":-0.22144,"marketCap":4370577},{"date":"2023-04-14","current":-0.203676,"twenty":-3.992628,"median":-0.624837,"eighty":-0.218547,"marketCap":4923327},{"date":"2023-04-21","current":-0.218035,"twenty":-3.838075,"median":-0.616531,"eighty":-0.218035,"marketCap":5270402},{"date":"2023-04-28","current":-0.207399,"twenty":-3.812316,"median":-0.595341,"eighty":-0.211114,"marketCap":5013309},{"date":"2023-05-05","current":-0.186,"twenty":-3.72216,"median":-0.589774,"eighty":-0.207399,"marketCap":4496040},{"date":"2023-05-12","current":-0.170057,"twenty":-3.593365,"median":-0.578926,"eighty":-0.203676,"marketCap":4110665},{"date":"2023-05-19","current":-0.138524,"twenty":-3.078187,"median":-0.574237,"eighty":-0.198975,"marketCap":3519757},{"date":"2023-05-26","current":-0.119818,"twenty":-2.975152,"median":-0.564854,"eighty":-0.195168,"marketCap":3044461},{"date":"2023-06-02","current":-0.12184,"twenty":-2.799991,"median":-0.554475,"eighty":-0.191738,"marketCap":3095845},{"date":"2023-06-09","current":-0.11729,"twenty":-2.663469,"median":-0.544325,"eighty":-0.188162,"marketCap":2980232},{"date":"2023-06-16","current":-0.120324,"twenty":-2.403304,"median":-0.537744,"eighty":-0.185529,"marketCap":3057307},{"date":"2023-06-22","current":-0.110212,"twenty":-2.331179,"median":-0.512831,"eighty":-0.181667,"marketCap":2800390},{"date":"2023-06-30","current":-0.089484,"twenty":-2.31186,"median":-0.504284,"eighty":-0.180301,"marketCap":2273711},{"date":"2023-07-07","current":-0.108696,"twenty":-2.269358,"median":-0.500344,"eighty":-0.179074,"marketCap":2761853},{"date":"2023-07-14","current":-0.095551,"twenty":-2.235871,"median":-0.48602,"eighty":-0.176463,"marketCap":2427861},{"date":"2023-07-21","current":-0.228917,"twenty":-2.222992,"median":-0.463108,"eighty":-0.17453,"marketCap":5816563},{"date":"2023-07-28","current":-0.230007,"twenty":-2.204961,"median":-0.448416,"eighty":-0.176463,"marketCap":5844261},{"date":"2023-08-04","current":-0.212566,"twenty":-2.189506,"median":-0.439793,"eighty":-0.177048,"marketCap":5401094},{"date":"2023-08-11","current":-0.213656,"twenty":-2.17405,"median":-0.436546,"eighty":-0.178163,"marketCap":5428792},{"date":"2023-08-18","current":-0.284273,"twenty":-2.145715,"median":-0.431596,"eighty":-0.17894,"marketCap":5612832},{"date":"2023-08-25","current":-0.281373,"twenty":-2.132836,"median":-0.405938,"eighty":-0.179667,"marketCap":5555558},{"date":"2023-09-01","current":-0.268319,"twenty":-2.119956,"median":-0.373875,"eighty":-0.180213,"marketCap":5297826},{"date":"2023-09-08","current":-0.274121,"twenty":-2.107077,"median":-0.367186,"eighty":-0.180403,"marketCap":5412374},{"date":"2023-09-15","current":-0.255266,"twenty":-2.08647,"median":-0.356221,"eighty":-0.180828,"marketCap":5040094},{"date":"2023-09-22","current":-0.23061,"twenty":-2.083894,"median":-0.35054,"eighty":-0.181286,"marketCap":4553267},{"date":"2023-09-29","current":-0.197251,"twenty":-2.073591,"median":-0.336589,"eighty":-0.182977,"marketCap":3894618},{"date":"2023-10-06","current":-0.159541,"twenty":-2.068439,"median":-0.324381,"eighty":-0.181273,"marketCap":3150059},{"date":"2023-10-12","current":-0.175495,"twenty":-2.047832,"median":-0.319777,"eighty":-0.180154,"marketCap":3465064},{"date":"2023-10-20","current":-0.224808,"twenty":-2.041392,"median":-0.319097,"eighty":-0.180301,"marketCap":4438719},{"date":"2023-10-27","current":-0.15519,"twenty":-2.038816,"median":-0.31805,"eighty":-0.180213,"marketCap":3064148},{"date":"2023-11-03","current":-0.147166,"twenty":-2.034952,"median":-0.312913,"eighty":-0.177994,"marketCap":2905715},{"date":"2023-11-10","current":-0.135455,"twenty":-2.034952,"median":-0.311621,"eighty":-0.175524,"marketCap":2674479},{"date":"2023-11-17","current":-0.234708,"twenty":-2.022073,"median":-0.305807,"eighty":-0.175796,"marketCap":2957311},{"date":"2023-11-24","current":-0.219726,"twenty":-1.970555,"median":-0.300549,"eighty":-0.176418,"marketCap":2768546},{"date":"2023-12-01","current":-0.284645,"twenty":-1.951236,"median":-0.295186,"eighty":-0.17653,"marketCap":3586526},{"date":"2023-12-08","current":-0.245519,"twenty":-1.931917,"median":-0.292717,"eighty":-0.177824,"marketCap":3093536},{"date":"2023-12-15","current":-0.25718,"twenty":-1.931917,"median":-0.287495,"eighty":-0.178672,"marketCap":3240458},{"date":"2023-12-22","current":-0.26467,"twenty":-1.893278,"median":-0.287174,"eighty":-0.179342,"marketCap":3334840},{"date":"2023-12-29","current":-0.25718,"twenty":-1.839184,"median":-0.286889,"eighty":-0.179829,"marketCap":3240458},{"date":"2024-01-05","current":-0.287142,"twenty":-1.800546,"median":-0.286002,"eighty":-0.180183,"marketCap":3617987},{"date":"2024-01-12","current":-0.352061,"twenty":-1.787667,"median":-0.286889,"eighty":-0.180403,"marketCap":4435967},{"date":"2024-01-19","current":-0.29713,"twenty":-1.777363,"median":-0.287142,"eighty":-0.180809,"marketCap":3743830},{"date":"2024-01-26","current":-0.374533,"twenty":-1.738725,"median":-0.287142,"eighty":-0.180905,"marketCap":4719114},{"date":"2024-02-02","current":-0.36954,"twenty":-1.648569,"median":-0.287174,"eighty":-0.181297,"marketCap":4656192},{"date":"2024-02-09","current":-0.294633,"twenty":-1.62281,"median":-0.290994,"eighty":-0.182747,"marketCap":3712369},{"date":"2024-02-16","current":-0.476633,"twenty":-1.609931,"median":-0.289857,"eighty":-0.182811,"marketCap":6005566},{"date":"2024-02-23","current":-0.47931,"twenty":-1.589324,"median":-0.293303,"eighty":-0.183477,"marketCap":6039299},{"date":"2024-03-01","current":-0.49934,"twenty":-1.563565,"median":-0.295134,"eighty":-0.185529,"marketCap":6291674},{"date":"2024-03-08","current":-0.420937,"twenty":-1.537806,"median":-0.29713,"eighty":-0.187269,"marketCap":5303792},{"date":"2024-03-15","current":-0.401657,"twenty":-1.522351,"median":-0.301226,"eighty":-0.187592,"marketCap":5060871},{"date":"2024-03-22","current":-0.539343,"twenty":-1.509471,"median":-0.306121,"eighty":-0.187752,"marketCap":5724083},{"date":"2024-03-28","current":-0.552464,"twenty":-1.475984,"median":-0.311621,"eighty":-0.188069,"marketCap":5863337},{"date":"2024-04-05","current":-0.582158,"twenty":-1.455377,"median":-0.312913,"eighty":-0.188946,"marketCap":6178491},{"date":"2024-04-12","current":-0.520524,"twenty":-1.44765,"median":-0.317056,"eighty":-0.189992,"marketCap":5524363},{"date":"2024-04-19","current":-0.400674,"twenty":-1.43477,"median":-0.319149,"eighty":-0.190623,"marketCap":4252385},{"date":"2024-04-26","current":-0.390727,"twenty":-1.426836,"median":-0.324381,"eighty":-0.191499,"marketCap":4146813},{"date":"2024-05-03","current":-0.406665,"twenty":-1.420036,"median":-0.328965,"eighty":-0.192296,"marketCap":4315962},{"date":"2024-05-10","current":-0.38701,"twenty":-1.416739,"median":-0.333012,"eighty":-0.192744,"marketCap":4107370},{"date":"2024-05-17","current":-0.414034,"twenty":-1.409012,"median":-0.340203,"eighty":-0.194261,"marketCap":4778658},{"date":"2024-05-24","current":-0.386958,"twenty":-1.400239,"median":-0.345309,"eighty":-0.195168,"marketCap":4466149},{"date":"2024-05-31","current":-0.38446,"twenty":-1.397663,"median":-0.35054,"eighty":-0.195327,"marketCap":4437325},{"date":"2024-06-07","current":-0.35929,"twenty":-1.394844,"median":-0.352061,"eighty":-0.195908,"marketCap":4146813},{"date":"2024-06-14","current":-0.348315,"twenty":-1.39098,"median":-0.352127,"eighty":-0.196588,"marketCap":4020141},{"date":"2024-06-21","current":-0.358489,"twenty":-1.39098,"median":-0.352127,"eighty":-0.197251,"marketCap":4137567},{"date":"2024-06-28","current":-0.352192,"twenty":-1.39098,"median":-0.352192,"eighty":-0.197427,"marketCap":4064893},{"date":"2024-07-05","current":-0.295739,"twenty":-1.39098,"median":-0.352061,"eighty":-0.197948,"marketCap":3413327},{"date":"2024-07-12","current":-0.308291,"twenty":-1.39098,"median":-0.35054,"eighty":-0.199037,"marketCap":3558204},{"date":"2024-07-15","current":-0.302639,"twenty":-1.39098,"median":-0.349428,"eighty":-0.199099,"marketCap":3492971},{"date":"2024-08-02","current":-0.303954,"twenty":-1.39098,"median":-0.348315,"eighty":-0.199161,"marketCap":3508142},{"date":"2024-08-09","current":-0.241717,"twenty":-1.387116,"median":-0.345859,"eighty":-0.199565,"marketCap":2789826},{"date":"2024-08-16","current":-0.26447,"twenty":-1.380677,"median":-0.342074,"eighty":-0.199992,"marketCap":2982489},{"date":"2024-08-23","current":-0.307981,"twenty":-1.378101,"median":-0.336589,"eighty":-0.20065,"marketCap":3473180},{"date":"2024-08-30","current":-0.307305,"twenty":-1.370373,"median":-0.334845,"eighty":-0.202073,"marketCap":3465556},{"date":"2024-09-06","current":-0.364516,"twenty":-1.360069,"median":-0.341743,"eighty":-0.202979,"marketCap":4110738},{"date":"2024-09-13","current":-0.306193,"twenty":-1.352342,"median":-0.340037,"eighty":-0.203419,"marketCap":3453020},{"date":"2024-09-20","current":-0.321066,"twenty":-1.320968,"median":-0.335355,"eighty":-0.203676,"marketCap":3620738},{"date":"2024-09-27","current":-0.26527,"twenty":-1.261837,"median":-0.332941,"eighty":-0.20384,"marketCap":2991521},{"date":"2024-10-04","current":-0.225611,"twenty":-1.240811,"median":-0.332086,"eighty":-0.204208,"marketCap":2544273},{"date":"2024-10-11","current":-0.228772,"twenty":-1.222236,"median":-0.329966,"eighty":-0.204208,"marketCap":2579914},{"date":"2024-10-18","current":-0.220531,"twenty":-1.190942,"median":-0.325844,"eighty":-0.204432,"marketCap":2486982},{"date":"2024-10-25","current":-0.387436,"twenty":-1.154623,"median":-0.327156,"eighty":-0.205107,"marketCap":4369210},{"date":"2024-10-31","current":-0.78508,"twenty":-1.119973,"median":-0.329966,"eighty":-0.206243,"marketCap":8853546},{"date":"2024-11-08","current":-0.85568,"twenty":-1.097263,"median":-0.332086,"eighty":-0.207117,"marketCap":9649713},{"date":"2024-11-15","current":-1.112489,"twenty":-1.111833,"median":-0.332941,"eighty":-0.207179,"marketCap":8817483},{"date":"2024-11-22","current":-1.463005,"twenty":-1.187197,"median":-0.335355,"eighty":-0.2074,"marketCap":11595645},{"date":"2024-11-29","current":-1.219747,"twenty":-1.20095,"median":-0.339535,"eighty":-0.207404,"marketCap":9667605},{"date":"2024-12-06","current":-1.19258,"twenty":-1.236427,"median":-0.343222,"eighty":-0.208116,"marketCap":9452284},{"date":"2024-12-13","current":-1.007606,"twenty":-1.236427,"median":-0.346409,"eighty":-0.208205,"marketCap":7986196},{"date":"2024-12-20","current":-1.3089,"twenty":-1.236427,"median":-0.348396,"eighty":-0.208854,"marketCap":10374225},{"date":"2024-12-27","current":-1.541045,"twenty":-1.25409,"median":-0.351152,"eighty":-0.20886,"marketCap":12214182},{"date":"2025-01-03","current":-1.358293,"twenty":-1.336231,"median":-0.352061,"eighty":-0.209,"marketCap":10765705},{"date":"2025-01-10","current":-1.303961,"twenty":-1.349402,"median":-0.352192,"eighty":-0.209431,"marketCap":10335077},{"date":"2025-01-17","current":-1.152491,"twenty":-1.345121,"median":-0.352708,"eighty":-0.209959,"marketCap":9134538},{"date":"2025-01-24","current":-1.307254,"twenty":-1.346768,"median":-0.358489,"eighty":-0.210043,"marketCap":10361175},{"date":"2025-01-31","current":-1.104745,"twenty":-1.338865,"median":-0.359421,"eighty":-0.21027,"marketCap":8756107},{"date":"2025-02-07","current":-1.053706,"twenty":-1.330304,"median":-0.362904,"eighty":-0.210466,"marketCap":8351577},{"date":"2025-02-14","current":-0.996081,"twenty":-1.315486,"median":-0.36403,"eighty":-0.21134,"marketCap":7894850},{"date":"2025-02-21","current":-0.926932,"twenty":-1.3089,"median":-0.364942,"eighty":-0.212244,"marketCap":7346778},{"date":"2025-02-28","current":-0.864368,"twenty":-1.307254,"median":-0.367373,"eighty":-0.212536,"marketCap":6850903},{"date":"2025-03-07","current":-0.856136,"twenty":-1.303961,"median":-0.371707,"eighty":-0.212566,"marketCap":6785656},{"date":"2025-03-14","current":-0.637359,"twenty":-1.279265,"median":-0.374533,"eighty":-0.212566,"marketCap":5090547},{"date":"2025-03-21","current":-0.626307,"twenty":-1.273906,"median":-0.375127,"eighty":-0.213521,"marketCap":5002277},{"date":"2025-03-28","current":-0.548899,"twenty":-1.249136,"median":-0.377888,"eighty":-0.213656,"marketCap":4384018},{"date":"2025-04-04","current":-0.402877,"twenty":-1.247983,"median":-0.38361,"eighty":-0.213683,"marketCap":3217756},{"date":"2025-04-11","current":-0.330747,"twenty":-1.243734,"median":-0.377888,"eighty":-0.213752,"marketCap":2641651},{"date":"2025-04-17","current":-0.330747,"twenty":-1.241359,"median":-0.377888,"eighty":-0.214536,"marketCap":2641651},{"date":"2025-04-25","current":-0.582325,"twenty":-1.237295,"median":-0.37685,"eighty":-0.214732,"marketCap":4650993},{"date":"2025-05-02","current":-0.522509,"twenty":-1.233817,"median":-0.383262,"eighty":-0.215726,"marketCap":4173247},{"date":"2025-05-09","current":-0.365932,"twenty":-1.222431,"median":-0.382514,"eighty":-0.21608,"marketCap":2922678},{"date":"2025-05-16","current":-0.441183,"twenty":-1.219747,"median":-0.383262,"eighty":-0.217023,"marketCap":3006986},{"date":"2025-05-23","current":-0.447368,"twenty":-1.206773,"median":-0.38446,"eighty":-0.217878,"marketCap":3049140},{"date":"2025-05-30","current":-0.451491,"twenty":-1.201982,"median":-0.384903,"eighty":-0.218264,"marketCap":3077243},{"date":"2025-06-06","current":-0.564674,"twenty":-1.195928,"median":-0.386958,"eighty":-0.218495,"marketCap":3848663},{"date":"2025-06-13","current":-0.516411,"twenty":-1.19104,"median":-0.388248,"eighty":-0.21863,"marketCap":3519717},{"date":"2025-06-20","current":-0.513998,"twenty":-1.188835,"median":-0.39137,"eighty":-0.218686,"marketCap":3503270},{"date":"2025-06-27","current":-0.535716,"twenty":-1.185222,"median":-0.394081,"eighty":-0.219102,"marketCap":3651296},{"date":"2025-07-03","current":-0.557434,"twenty":-1.182061,"median":-0.399017,"eighty":-0.219726,"marketCap":3799321},{"date":"2025-07-11","current":-0.504345,"twenty":-1.180151,"median":-0.399987,"eighty":-0.219813,"marketCap":3437481},{"date":"2025-07-18","current":-0.751307,"twenty":-1.178504,"median":-0.401019,"eighty":-0.22017,"marketCap":5120707},{"date":"2025-07-25","current":-0.76522,"twenty":-1.176936,"median":-0.401964,"eighty":-0.220207,"marketCap":5215535},{"date":"2025-08-01","current":-0.726959,"twenty":-1.175387,"median":-0.402877,"eighty":-0.220276,"marketCap":4954758},{"date":"2025-08-08","current":-0.723481,"twenty":-1.169069,"median":-0.405593,"eighty":-0.220392,"marketCap":4931051},{"date":"2025-08-15","current":-0.929108,"twenty":-1.150186,"median":-0.408094,"eighty":-0.220472,"marketCap":6114994},{"date":"2025-08-22","current":-0.933618,"twenty":-1.139069,"median":-0.409736,"eighty":-0.220573,"marketCap":6144679},{"date":"2025-08-29","current":-0.947149,"twenty":-1.130745,"median":-0.414034,"eighty":-0.220768,"marketCap":6233732},{"date":"2025-09-05","current":-0.9697,"twenty":-1.127795,"median":-0.418503,"eighty":-0.220875,"marketCap":6382154},{"date":"2025-09-12","current":-0.960724,"twenty":-1.122663,"median":-0.421877,"eighty":-0.221392,"marketCap":6323082},{"date":"2025-09-19","current":-0.947149,"twenty":-1.117916,"median":-0.425864,"eighty":-0.22144,"marketCap":6233732},{"date":"2025-09-26","current":-1.019312,"twenty":-1.112489,"median":-0.430234,"eighty":-0.221723,"marketCap":6708683},{"date":"2025-10-03","current":-1.105007,"twenty":-1.11133,"median":-0.434538,"eighty":-0.221973,"marketCap":7272687},{"date":"2025-10-10","current":-1.050884,"twenty":-1.11133,"median":-0.435042,"eighty":-0.224695,"marketCap":6916474},{"date":"2025-10-17","current":-1.15913,"twenty":-1.114027,"median":-0.436493,"eighty":-0.224808,"marketCap":7628901},{"date":"2025-10-24","current":-0.951659,"twenty":-1.114027,"median":-0.438675,"eighty":-0.225611,"marketCap":6263416},{"date":"2025-10-31","current":-0.97421,"twenty":-1.112489,"median":-0.441183,"eighty":-0.225647,"marketCap":6411839},{"date":"2025-11-07","current":-0.933618,"twenty":-1.11133,"median":-0.4464,"eighty":-0.225968,"marketCap":6144679},{"date":"2025-11-14","current":-0.933618,"twenty":-1.109517,"median":-0.447368,"eighty":-0.226737,"marketCap":6144679},{"date":"2025-11-21","current":-0.519612,"twenty":-1.109211,"median":-0.450935,"eighty":-0.227075,"marketCap":5701431},{"date":"2025-11-28","current":-0.571251,"twenty":-1.10856,"median":-0.452846,"eighty":-0.227389,"marketCap":6268033},{"date":"2025-12-05","current":-0.526067,"twenty":-1.105685,"median":-0.460769,"eighty":-0.227585,"marketCap":5772257},{"date":"2025-12-12","current":-0.470074,"twenty":-1.104797,"median":-0.465167,"eighty":-0.227723,"marketCap":5157875},{"date":"2025-12-19","current":-0.377383,"twenty":-1.097738,"median":-0.463108,"eighty":-0.228568,"marketCap":4140829},{"date":"2025-12-26","current":-0.367452,"twenty":-1.095986,"median":-0.455656,"eighty":-0.228845,"marketCap":4031860},{"date":"2026-01-02","current":-0.304555,"twenty":-1.094182,"median":-0.452138,"eighty":-0.228893,"marketCap":3341722},{"date":"2026-01-09","current":-0.3509,"twenty":-1.089539,"median":-0.450036,"eighty":-0.228903,"marketCap":3850245},{"date":"2026-01-16","current":-0.297934,"twenty":-1.081354,"median":-0.447139,"eighty":-0.228917,"marketCap":3269076},{"date":"2026-01-23","current":-0.294194,"twenty":-1.072533,"median":-0.445907,"eighty":-0.228952,"marketCap":3228031},{"date":"2026-01-30","current":-0.238347,"twenty":-1.067528,"median":-0.440503,"eighty":-0.229277,"marketCap":2615261},{"date":"2026-02-06","current":-0.151946,"twenty":-1.060629,"median":-0.437558,"eighty":-0.228917,"marketCap":1667228},{"date":"2026-02-13","current":-0.136719,"twenty":-1.055386,"median":-0.43596,"eighty":-0.227954,"marketCap":1500142},{"date":"2026-02-20","current":-0.132581,"twenty":-1.055352,"median":-0.435042,"eighty":-0.227075,"marketCap":1454738},{"date":"2026-02-27","current":-0.13076,"twenty":-1.054591,"median":-0.434538,"eighty":-0.225611,"marketCap":1434761},{"date":"2026-03-06","current":-0.178396,"twenty":-1.053706,"median":-0.430234,"eighty":-0.221723,"marketCap":1957450},{"date":"2026-03-13","current":-0.143671,"twenty":-1.050884,"median":-0.425864,"eighty":-0.220741,"marketCap":1576421},{"date":"2026-03-20","current":-0.190347,"twenty":-1.049469,"median":-0.421877,"eighty":-0.220251,"marketCap":2088576},{"date":"2026-03-27","current":-0.181078,"twenty":-1.04712,"median":-0.418503,"eighty":-0.219726,"marketCap":1986871},{"date":"2026-04-02","current":-0.195256,"twenty":-1.046523,"median":-0.414034,"eighty":-0.218521,"marketCap":1986871},{"date":"2026-04-10","current":-0.441293,"twenty":-1.046374,"median":-0.419505,"eighty":-0.218658,"marketCap":4490464},{"date":"2026-04-17","current":-0.464999,"twenty":-1.037751,"median":-0.422817,"eighty":-0.218686,"marketCap":4731687},{"date":"2026-04-24","current":-0.386587,"twenty":-1.031439,"median":-0.421877,"eighty":-0.219518,"marketCap":3933795},{"date":"2026-05-01","current":-0.338811,"twenty":-1.02153,"median":-0.418503,"eighty":-0.219726,"marketCap":3447637},{"date":"2026-05-08","current":-0.337352,"twenty":-1.019167,"median":-0.413916,"eighty":-0.220076,"marketCap":3432793},{"date":"2026-05-15","current":-0.25274,"twenty":-1.015668,"median":-0.410815,"eighty":-0.220189,"marketCap":2571811},{"date":"2026-05-22","current":-0.254329,"twenty":-1.014314,"median":-0.409355,"eighty":-0.22024,"marketCap":2997663},{"date":"2026-05-29","current":-0.236933,"twenty":-1.011852,"median":-0.407544,"eighty":-0.220326,"marketCap":2792623},{"date":"2026-06-05","current":-0.234729,"twenty":-1.00868,"median":-0.404521,"eighty":-0.220229,"marketCap":2766645},{"date":"2026-06-12","current":-0.207415,"twenty":-1.006512,"median":-0.402877,"eighty":-0.21931,"marketCap":2444705},{"date":"2026-06-18","current":-0.212374,"twenty":-1.005782,"median":-0.401964,"eighty":-0.218603,"marketCap":2503155},{"date":"2026-06-26","current":-0.352821,"twenty":-1.003219,"median":-0.401019,"eighty":-0.218686,"marketCap":4158541},{"date":"2026-07-02","current":-0.376135,"twenty":-1.000656,"median":-0.400947,"eighty":-0.219547,"marketCap":4433328},{"date":"2026-07-10","current":-0.345341,"twenty":-1.000656,"median":-0.400947,"eighty":-0.220351,"marketCap":4070374},{"date":"2026-07-17","current":-0.34584,"twenty":-1.000656,"median":-0.400947,"eighty":-0.220699,"marketCap":4076252},{"date":"2026-07-24","current":-0.339855,"twenty":-1.000656,"median":-0.400947,"eighty":-0.221666,"marketCap":4005718},{"date":"2026-07-31","current":-0.320406,"twenty":-1.001937,"median":-0.400983,"eighty":-0.225633,"marketCap":3776484},{"date":"2026-08-07","current":-0.653654,"twenty":-1.001937,"median":-0.401964,"eighty":-0.227556,"marketCap":7704322},{"date":"2026-08-14","current":-0.434481,"twenty":-1.001937,"median":-0.405593,"eighty":-0.228907,"marketCap":5121030},{"date":"2026-08-21","current":-0.485647,"twenty":-0.985034,"median":-0.405593,"eighty":-0.228907,"marketCap":6130756}],"updateTime":1787544338664},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENSC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635058352","title":"BRIEF-Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635058352","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635058352?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:49","pubTimestamp":1778878179,"startTime":"0","endTime":"0","summary":"BRIEF-Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC FilingMay 15  - Ensysce Biosciences Inc ENSC.O:ENSYSCE BIOSCIENCES INC - LAUNCHES FORMAL REVIEW OF STRATEGIC ALTERNATIVES - SEC FILINGSource text: [ID:n0001493152-26-023810]Further company coverage: ENSC.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S1FO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635205887","title":"Ensysce Biosciences Inc - Launches Formal Review of Strategic Alternatives - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635205887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635205887?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:48","pubTimestamp":1778878108,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S1FO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635897030","title":"Ensysce Biosciences Q1 EPS $(0.52) Beats $(0.73) Estimate, Sales $960.999K Miss $1.900M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635897030","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635897030?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:23","pubTimestamp":1778876583,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.73) by 28.77 percent. This is a 62.59 percent increase over losses of $(1.39) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52616370/ensysce-biosciences-q1-eps-0-52-beats-0-73-estimate-sales-960-999k-miss-1-900m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ensysce Biosciences Q1 EPS $(0.52) Beats $(0.73) Estimate, Sales $960.999K Miss $1.900M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635739037","title":"Ensysce Q1 FY26 net loss widens to $3.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635739037","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635739037?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:16","pubTimestamp":1778876162,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences posted a Q1 net loss attributable to common stockholders of USD 3.6 million, widening from USD 1.9 million a year earlier; loss per share narrowed to USD 0.52 from USD 1.39.R&D expense climbed to USD 3.3 million from USD 1.9 million on higher Phase 3 clinical trial activity for PF614, while G&A expense eased to USD 1.2 million from USD 1.4 million.Cash and cash equivalents fell to USD 745,482 at March 31 from USD 4.3 million at Dec. 31; net cash used in operating activities increased to USD 3.5 million from USD 1.7 million.Federal grants slipped to USD 960,999 from USD 1.32 million, while a second tranche of USD 2 million in convertible preferred stock financing closed April 7 under a facility for up to USD 20 million over 24 months.Operationally, PF614-301 Phase 3 trial reached 50% of interim enrollment target, IRB clearance secured to start Part 3 of PF614-MPAR-102, while board launched a formal review of strategic alternatives including partnerships and licensing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDLcc0GK1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634245366","title":"Ensysce announces expansion of patent protection for MPAR technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2634245366","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634245366?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:40","pubTimestamp":1778600441,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced that the Taiwan Intellectual Property Office issued a patent covering Ensysce’s MPAR technology. The patent, t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-announces-expansion-of-patent-protection-for-mpar-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-announces-expansion-of-patent-protection-for-mpar-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634167212","title":"Ensysce says Taiwan grants MPAR overdose-protection patent through 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2634167212","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634167212?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:01","pubTimestamp":1778587269,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences secured a Taiwan patent covering MPAR overdose-protection technology, extending jurisdictional protection through 2042.Patent includes composition-of-matter claims, method-of-use claims tied to enzyme-cleavable prodrugs, controlled-release nafamostat.Coverage expands U.S. Patent No. 12,599,578, issued April 14, 2026.MPAR holds FDA Breakthrough Therapy designation, aims to curb opioid release in overdose scenarios while maintaining pain relief when used as directed.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL4JwvB4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634328653","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2634328653","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634328653?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:57","pubTimestamp":1778500678,"startTime":"0","endTime":"0","summary":"Helport AI  shares were up 42% in Monday premarket activity, adding to Friday's rally.Everspin Technologies  shares were 41% higher, extending gains from the previous session.Ensysce Biosciences  stock was up 15%, recovering from Friday's loss.Intel  stock was 5.7% higher after The Wall Street Journal reported Friday that Apple  and Intel reached a preliminary agreement under which the company will make some of the chips powering Apple devices.Emerald  shares were up 11% after Apollo Global Management  said its managed funds signed definitive agreements to purchase Emerald and Questex to form a combined business events platform.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2247934214.USD","LU0820561818.USD","IE00BFSS8Q28.SGD","LU2065169927.USD","SG9999000418.SGD","LU1037948541.HKD","LU1839511570.USD","LU2054465674.USD","LU2092937148.SGD","SG9999015358.SGD","LU1668664300.SGD","LU2089985449.USD","LU0348723411.USD","LU1366192091.USD","LU2237443622.USD","LU2462591350.SGD","LU0964807845.USD","LU2430703095.HKD","LU0494093205.USD","LU2089284900.SGD","LU0795875086.SGD","LU0080751232.USD","LU2505996509.AUD","LU1244550494.USD","IE000M9KFDE8.USD","LU1066051811.HKD","LU0985320562.USD","LU2237438978.USD","LU0672654240.SGD","IE00BJJMRX11.SGD","LU2357305700.SGD","LU2237443382.USD","IE00B19Z9505.USD","LU0238689110.USD","LU2168564495.EUR","LU0823434583.USD","LU0528227936.USD","LU1235294995.USD","LU0314106906.USD","LU0708995401.HKD","LU2047632596.USD","LU0889565833.HKD","LU0545039389.USD","LU1301847155.USD","BK4576","LU2097344357.USD","LU0683600562.USD","LU0784385840.USD","IE00B7KXQ091.USD","LU2471134796.USD","SG9999014906.USD","LU2552382132.HKD","LU0642271901.SGD","LU0444971666.USD","LU0048584097.USD","LU0788109477.HKD","IE00BN8TJ469.HKD","LU1989764748.USD","IE00B1XK9C88.USD","LU1934455277.USD","LU1323610961.USD","LU1778281490.HKD","BK4515","LU0949170426.SGD","LU2213496289.HKD","LU2471134952.CNY","LU0354030511.USD","SG9999018865.SGD","IE0004091025.USD","LU1814569148.SGD","LU0949170772.SGD","LU0323591593.USD","LU2133065610.SGD","AAPW","LU2430703178.SGD","LU1582986359.USD","LU1582987597.SGD","LU0203202063.USD","LU1791807156.HKD","LU2361044865.SGD","LU1674673428.USD","IE00B3SWFQ91.USD","LU0661504455.SGD","SG9999017495.SGD","LU2125154778.USD","BK4571","LU0077335932.USD","BK4554","IE00B19Z3581.USD","SG9999015341.SGD","IE000BZT7R73.USD","IE00BJTD4N35.SGD","IE00B4YYXB79.USD","LU0314104364.USD","LU1823568750.SGD","BK4527","LU2271345857.HKD","LU2236285917.USD","LU0251132253.USD","IE000F7OJYX1.SGD","LU2083900584.USD","LU1244550577.SGD","LU0726765562.USD","LU0868494617.USD","INTW","LU1116320737.USD","IE0034235295.USD","LU0719512351.SGD","HPAI","IE000SO60NU8.SGD","LU2097344431.USD","LU2458330243.SGD","BK4533","LU3102509885.SGD","LU1037948897.HKD","LU0265550359.USD","BK4579","HK0000914660.USD","LU0345768740.USD","LU0353189763.USD","LU0784383803.USD","BK4141","LU0882574139.USD","IE00BDCRKT87.USD","LU2100268510.USD","LU1804176565.USD","LU2417539215.USD","HK0000306685.HKD","LU0861579265.USD","LU2381873111.SGD","SG9999002232.USD","BK4592","IE00BJTD4V19.USD","LU0820562030.AUD","LU1571399168.USD","IE00BSNM7G36.USD","LU2403377893.USD","IE00BK4W5M84.HKD","IE00B1BXHZ80.USD","LU2461242641.AUD","LU2860962120.EUR","LU2023251221.USD","LU0082616367.USD","GB00BDT5M118.USD","LINT","LU2756315318.SGD","IE000MB6IJN5.SGD","IE00B19Z8W00.USD","LU1548497426.USD","LU1791710582.SGD","LU0215105999.USD","LU1720051108.HKD","LU0965509283.SGD","LU0011850046.USD","LU0170899867.USD","LU1732799900.SGD","LU2087625088.SGD","AAPU","LU0096362180.USD","MRAM","LU1699723380.USD","AAPY","BK4184","LU0133085943.USD","LU0784384876.USD","HK0000819398.USD","LU2087621335.USD","LU2543165471.USD","LU0965509101.SGD","LU0689626769.HKD","LU1935042215.USD","IE00BLSP4239.USD","LU1366333091.USD","IE00BK4W5L77.USD","LU0417517546.SGD","LU2242649171.HKD","LU2552382058.USD","LU0056508442.USD","LU0267386448.USD","LU1974910355.USD","LU2487616109.SGD","LU0106831901.USD","LU2250418816.HKD","LU2111349929.HKD","LU0957808578.USD","LU1868837136.USD","LU1069344957.HKD","SG9999015986.USD","INTC","LU1917777945.USD","IE0002270589.USD","AAPL","BK4507","LU1935042991.SGD","LU0345770308.USD","LU0210536198.USD","LU0784385170.HKD","LU1119994496.HKD","LU1988902786.USD","SG9999001424.SGD","LU2637965513.SGD","LU0053666078.USD","LU0724617625.USD","LU0557290698.USD","IE00BWXC8680.SGD","LU0198837287.USD","LU2361045086.USD","IE00B19Z8X17.USD","LU0308772762.SGD","LU0157215616.USD","BK4535","LU1815336760.USD","LU1551013425.SGD","BK4534","IE00BFSS7M15.SGD","LU0943347566.SGD","LU1934455863.HKD","BK4135","LU0124676726.USD","LU0321505868.SGD","LU1064131342.USD","LU1868836914.USD","LU0143551892.USD","LU2063271972.USD","IE0034235303.USD","LU1914381329.SGD","IE0003U64NQ7.SGD","LU0640476718.USD","LU0476273544.USD","LU0081259029.USD","LU2931357623.SGD","LU1852331112.SGD","LU1066051498.USD","BK4602","IE00B19Z3B42.SGD","LU1267930730.SGD","IE00BDRTCR15.USD","LU2347655156.SGD","LU1989771016.USD","LU2237443549.SGD","LU1642822529.SGD","LU0316494557.USD","BK4170","IE00BJLML261.HKD","BK4612","IE00BN29S564.USD","LU0738911758.USD","LU1989772840.SGD","04335","BK4573","LU1206712785.SGD","LU1989772923.USD","LU1316542783.SGD","LU2065171402.SGD","BK4505","LU1506573853.SGD","LU1496350502.SGD","LU0210528500.USD","IE0005OL40V9.USD","LU2065170008.USD","LU1989764664.SGD","LU2242650005.HKD","LU0942090050.USD","LU2191332357.HKD","LU2237443465.HKD","LU1935043536.SGD","IE000W1ABFV2.USD","LU0320765059.SGD","LU0456855351.SGD","LU1066051225.USD","LU1496350171.SGD","MACW.SI","SGXZ31699556.SGD","HK0000320264.USD","BK4553","LU0174119429.USD","LU2756315664.SGD","LU2264538146.SGD","IE00BKVL7J92.USD","LU0256863902.USD","LU1242518857.USD","LU1116320901.HKD","LU1084165304.USD","IE00B4JS1V06.HKD","LU0965509010.AUD","LU0234572021.USD","APLY","LU0234570918.USD","IE00B3S45H60.SGD","LU0154236417.USD","LU0345768153.USD","LU0553294199.USD","LU2954938101.SGD","IE00BBT3K403.USD","LU1066053197.SGD","LU2092627202.USD","BK4575","LU1732800096.USD","LU2430703251.USD","LU0511384066.AUD","BK4559","LU0472753341.HKD","LU0786609619.USD","LU0158827781.USD","LU2462591277.SGD","LU0265550946.USD","LU2089283258.USD","LU2746668974.SGD","LU0868494708.USD","LU2237443978.SGD","EEX","LU1868837300.USD","LU1718418525.SGD","HK0000306701.USD","LU0006061336.USD","LU2360106780.USD","LU2360032135.SGD","LU0158827948.USD","LU2237443895.HKD","BK4605","LU2420271590.USD","LU2286300806.USD","BK4550","LU0127658192.USD","LU1803068979.SGD","IE0000B7K699.USD","LU1935042488.USD","IE0004445239.USD","LU1291159041.SGD","AAPX","LU0097036916.USD","BK4023","LU1674673691.USD","LU0345770993.USD","IE00B775H168.HKD","IE0004445015.USD","LU2023250843.SGD","LU2077746001.SGD","LU0061475181.USD","LU2028103732.USD","BK4543","LU2361044949.HKD","HK0000914686.HKD","LU2750360997.AUD","LU0096364046.USD","LU0210533765.USD","LU0820561909.HKD","BK4139","LU2458330169.SGD","LU1035775433.USD","SG9999002224.SGD","LU1003077747.HKD","SG9999014914.USD","LU0072462426.USD","BK4566","AAPD","LU2347655073.USD","IE00BJJMRY28.SGD","LU0345769128.USD","LU2592432038.USD","SG9999018857.SGD","LU2452424414.USD","LU0061474960.USD","LU0289961442.SGD","SG9999014880.SGD","LU0957791311.USD","SG9999014898.SGD","LU0965508806.USD","LU0149725797.USD","LU1868836757.USD","LU0274383776.USD","LU2168563687.JPY","HK0000532082.HKD","LU2065171311.SGD","IE000WAW04H5.SGD","BK4581","LU0079474960.USD","SG9999014559.SGD","LU0109391861.USD","LU2168564222.USD","LU1280957306.USD","LU0057025933.USD","LU1791710400.SGD","LU2265009873.SGD","LU0979878070.USD","APO","LU2602419157.SGD","SG9999015978.USD","LU2471134523.USD","LU0345769631.USD","IE00B5949003.HKD","LU1206713676.USD","LU1582986433.USD","LU0823421416.USD","LU2896262040.SGD","IE000ITXATA3.USD","LU0795875169.SGD","SG9999015945.SGD","LU1551013342.USD","LU2106854487.HKD","AAPB","LU1935043023.USD","BK4598","LU2108987350.USD","IE0004086264.USD","LU2552382215.SGD","BK4529","LU0912757837.SGD","LU0354030438.USD","LU0689472784.USD","LU2750360641.GBP","IE0001KFT4U8.USD","LU0787776722.HKD","SG9999015952.SGD","IE000KEQY171.SGD","LU1244550221.USD","LU2471134879.HKD","IE000YTNTUN2.SGD","BK4585","SG9999014542.SGD","LU0823434740.USD","LU1145028129.USD","BK4512","LU1868836591.USD","LU2999663052.SGD","BK4588","LU2462157665.USD","LU1629891620.HKD","BK4532","IE00BKDWB100.SGD","IE00BLSP4452.SGD","IE00BYXW3230.USD","IE00BZ1G4Q59.USD","LU0070217475.USD","LU0321505439.SGD","LU0823421333.USD","LU0444973449.USD","LU1582987324.SGD","LU2168564065.EUR","IE00B775SV38.USD","LU1261432733.SGD","IE0009G5SDU7.USD","LU2746668461.USD","LU0256863811.USD","LU0289739343.SGD","LU0353189680.USD","HK0000320223.HKD","LU2148611432.USD","LU1720051017.SGD","LU1934455194.USD","LU0466842654.USD","ENSC","BK4009","LU0109392836.USD","LU2023250504.SGD","LU1127390331.HKD","LU2023250330.USD","SG9999014575.USD","BK4574","LU1815333072.USD","LU2168564149.EUR","IE0009356076.USD","LU0069063385.USD","SG9999014567.USD","LU1046421795.USD","LU2505996681.GBP","LU1232071149.USD","LU2125154935.USD","LU0203201768.USD","LU1242518931.SGD","LU2456880835.USD","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467105","title":"Ensysce Biosciences Inc  expected to post a loss of 73 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467105","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467105?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:15","pubTimestamp":1778274919,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc  expected to post a loss of73cents a share - Earnings Preview Ensysce Biosciences Inc ENSC.OQ ENSC.O is expected to  show a rise in quarterly revenue when it reports  results o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2OC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633455958","title":"Ensysce CEO speaks at Pain Therapeutics Summit Europe in Amsterdam","url":"https://stock-news.laohu8.com/highlight/detail?id=2633455958","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633455958?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:00","pubTimestamp":1778241646,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences attended Pain Therapeutics Summit Europe in Amsterdam on May 7-8, 2026.CEO Lynn Kirkpatrick presented on chemically engineered opioids with built-in safety controls, highlighting TAAP and MPAR platforms, then joined a panel on safer analgesics without sacrificing efficacy.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL4m7tz8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629778641","title":"Ensysce Biosciences posts investor presentation on TAAP, MPAR opioid pain programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2629778641","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629778641?lang=en_us&edition=fundamental","pubTime":"2026-04-21 02:14","pubTimestamp":1776708847,"startTime":"0","endTime":"0","summary":"Ensysce outlined commercialization strategy centered on TAAP and MPAR platforms designed to provide abuse deterrence and overdose protection using trypsin-controlled activation.Lead candidate PF614 targets acute severe pain with Phase 3 program underway, including PF614-301 initiated in 2025.Company plans to initiate PF614-302 open-label bunionectomy study in 2026 to expand safety database supporting PF614 NDA targeted for 2027.PF614-MPAR, combination of PF614 with trypsin inhibitor nafamostat, is positioned for chronic pain with Phase 1 data presented as demonstrating overdose protection.Pipeline update highlighted FDA Fast Track designation for PF614 granted in January 2018, followed by FDA Breakthrough Therapy designation for TAAP oxycodone combination product granted in January 2024.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL7yR0Xx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627215766","title":"Ensysce secures IRB approval of final phase of PF614-MPAR-102 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2627215766","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627215766?lang=en_us&edition=fundamental","pubTime":"2026-04-16 21:08","pubTimestamp":1776344910,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced Investigational Review Board approval to initiate Part 3 of the PF614-MPAR-102 clinical study, marking the fin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-secures-irb-approval-of-final-phase-of-pf614-mpar-102-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-secures-irb-approval-of-final-phase-of-pf614-mpar-102-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627203290","title":"Ensysce gets IRB clearance to start final phase of PF614-MPAR-102 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2627203290","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627203290?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:09","pubTimestamp":1776341375,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences initiated final stage of PF614-MPAR-102 clinical study following IRB clearance.Previously published clinical data were already presented, showing PF614-MPAR maintained intended opioid exposure under prescribed use.Those results also indicated overdose-protection behavior, limiting additional opioid release when excessive oral doses were taken.Part 3 will be presented in future readouts, aiming to confirm protective effect across multiple dosing scenarios.Program supports Ensysce strategy to differentiate PF614-MPAR as a next-generation opioid with built-in oral overdose protection, extending MPAR platform toward other CNS categories.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDLbYq9gZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626750183","title":"Ensysce Biosciences files to sell 20.34M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2626750183","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626750183?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:12","pubTimestamp":1775729571,"startTime":"0","endTime":"0","summary":"06:05 EDT Ensysce Biosciences (ENSC) files to sell 20.34M shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-files-to-sell-20-34m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-files-to-sell-20-34m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625534639","title":"Ensysce Biosciences secures second financing from 2025 agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2625534639","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625534639?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:52","pubTimestamp":1775566376,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced the closing of a second convertible preferred stock financing of $2M under prior commitment in November 2025 o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-secures-second-financing-from-2025-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-secures-second-financing-from-2025-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","PFF","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625301369","title":"Ensysce Biosciences closes USD 2 million convertible preferred stock private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2625301369","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625301369?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:06","pubTimestamp":1775563584,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences closed a $2 million convertible preferred stock financing under a November 2025 commitment for up to $20 million over 24 months.Terms include a fixed conversion price of $0.55 per share.Structure also provides an alternate conversion price tied to average common stock prices before conversion.Financing includes 100% warrant coverage with an 18-month term.Additional 100% warrant coverage carries a five-year term.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL1LDf6t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624866432","title":"Ensysce Biosciences director Curtis Rosebraugh resigns from board","url":"https://stock-news.laohu8.com/highlight/detail?id=2624866432","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624866432?lang=en_us&edition=fundamental","pubTime":"2026-04-04 04:15","pubTimestamp":1775247333,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences director Curtis Rosebraugh resigned effective April 1, 2026.Rosebraugh served on Board Nominating and Corporate Governance Committee before stepping down.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDLbPL6bS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623248523","title":"Ensysce Biosciences Q4 EPS $(0.75) Misses $(0.70) Estimate, Sales $1.882M Beat $500.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2623248523","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623248523?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:24","pubTimestamp":1774905896,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.70) by 7.14 percent. This is a 74.14 percent increase over losses of $(2.90) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51554124/ensysce-biosciences-q4-eps-0-75-misses-0-70-estimate-sales-1-882m-beat-500-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ensysce Biosciences Q4 EPS $(0.75) Misses $(0.70) Estimate, Sales $1.882M Beat $500.000K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623124321","title":"Ensysce Biosciences Q4 net loss narrows to $2.8 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623124321","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623124321?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:02","pubTimestamp":1774904526,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Q4 net loss narrows to $2.8 mlnOverviewUS clinical-stage pharma reported Q4 net loss narrowed to $2.8 mlnIn 2025, company advanced PF614 to Phase 3 trial and PF614-MPAR under FDA B","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nL1N40I10Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623632157","title":"Ensysce FY25 net loss widens to $10 million; R&D expense climbs to $10 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623632157","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623632157?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:50","pubTimestamp":1774903844,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences posted a net loss attributable to common stockholders of $10.2 million for 2025.Federal grants, its revenue line item, edged down to $5.1 million.Operating loss widened to $10.2 million as R&D expenses climbed to $10.4 million due to higher external costs tied to PF614 and PF614-MPAR programs.Cash and cash equivalents rose to $4.3 million.Initiated pivotal Phase 3 PF614-301 trial with first patient enrolled; FDA feedback supported overdose-protection labeling and potential 505 pathway for PF614-MPAR, while management said enrollment is progressing rapidly and manufacturing readiness advanced.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL971RyS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623315733","title":"Ensysce Biosciences director Lee Rauch resigns from board amid retention package dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315733","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623315733?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:02","pubTimestamp":1774864932,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences received resignation of director Lee Rauch, effective March 24, 2026.Rauch previously served on Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee.Board moved forward with management retention arrangements tied to strategic alternatives, despite Rauch’s dissent.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL1sCyQw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":52,"code":"91000000","status":"200"}]}}